3 ms·
Frankly, I don't think such projects should be left up to the private sector to develop. If we did space travel that way we'd make the first moon landing in 203
by moffkalast 3y ago
Frankly, I don't think such projects should be left up to the private sector to develop. If we did space travel that way we'd make the first moon landing in 2038.
This sort of live saving research is the best contender for R&D by government grants, if it's a worthy cause it can be supported for a long time (like fusion is being), and when the solution is found it can be immediately shared and sold at cost for the benefit of everyone, not hoarded by one company and sold at a ridiculous price to people that are forced to buy it or die.
- jacobsimon 3y agoIt’s a funny comment because I think you could also argue that the government misappropriated a huge amount of public money to put a man on the moon in the 1960s, when it should have invested that into medical research or better transportation infrastructure in America. The fact that the private sector hasn’t developed moon travel yet is a sign that it’s just not that important to most people, not a lack of productivity.
- moffkalast 3y agoOr maybe that the return on investment is data they can't directly commercialize. Though I guess they could auction off pieces of the moon to the highest bidder or something of the sort. But yes I think we can all agree that that money could've been better or at least far more efficiently spent, same goes for the US's colossal military budget. This is in a nutshell the whole mindset behind the EU's spending the way I see it - social programs first, science second, everything else third.
- nradov 3y agoEnjoy it while it lasts. The EU countries have only been able to under spend on their militaries because of US security guarantees. That subsidy is coming to an end one way or another and they are rapidly increasing defense spending. That means austerity for social programs. In terms of novel drugs introduced per year (not just repackaging existing drugs), the EU as a bloc is consistently behind the US. So, their scientific spending doesn't seem to be paying off in pharmaceuticals.